Literature DB >> 12584391

Substance P-immunoreactive nerves in endobronchial biopsies in cough-variant asthma and classic asthma.

Sang Yeub Lee1, Min Kyung Kim, Chol Shin, Jae Jeong Shim, Han Kyeom Kim, Kyung Ho Kang, Se Hwa Yoo, Kwang Ho In.   

Abstract

BACKGROUND: Unlike classic asthma, cough-variant asthma does not show any evidence of airway obstruction. The main symptom is a dry cough with little known pathophysiology. Hypersensitivity of the cough receptors in cough-variant asthma and an increase in the sensory nerve density of the airway epithelium in persistent dry cough patients have been reported. Therefore, it is possible that there is a higher sensory nerve density in cough-variant asthma patients than in classic asthma patients.
OBJECTIVES: This study was undertaken to compare the substance P (SP)-immunoreactive nerve density in mucosal biopsies of cough-variant asthma patients, classic asthma patients, and in control subjects.
METHODS: Bronchoscopic biopsies were performed in 6 cough-variant asthma patients, 14 classic asthma patients, and 5 normal controls. The tissues obtained were stained immunohistochemically. The SP-immunoreactive nerve density was measured in the bronchial epithelium using a light microscope at 400 x magnification.
RESULTS: SP- immunoreactive nerve density for the cough-variant asthma group was significantly higher than that of the classic asthma group (p = 0.001), and of the normal control group (p = 0.006).
CONCLUSIONS: It is possible that a sensory nerve abnormality within the airway may be related to hypersensitivity of the cough receptor, and that this may be one of the pathophysiologies of cough-variant asthma. Copyright 2003 S. Karger AG, Basel

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12584391     DOI: 10.1159/000068413

Source DB:  PubMed          Journal:  Respiration        ISSN: 0025-7931            Impact factor:   3.580


  7 in total

1.  Increased tachykinin levels in induced sputum from asthmatic and cough patients with acid reflux.

Authors:  Robert N Patterson; Brian T Johnston; Joy E S Ardill; Liam G Heaney; Lorcan P A McGarvey
Journal:  Thorax       Date:  2007-01-24       Impact factor: 9.139

2.  Cough in asthma is due to eosinophilic airway inflammation: a pro/con debate.

Authors:  Akio Niimi; Christopher E Brightling; Peter V Dicpinigaitis
Journal:  Lung       Date:  2013-12-14       Impact factor: 2.584

Review 3.  Anatomy and neurophysiology of cough: CHEST Guideline and Expert Panel report.

Authors:  Brendan J Canning; Anne B Chang; Donald C Bolser; Jaclyn A Smith; Stuart B Mazzone; Lorcan McGarvey
Journal:  Chest       Date:  2014-12       Impact factor: 9.410

4.  Effects of treatment with montelukast alone, budesonide/formoterol alone and a combination of both in cough variant asthma.

Authors:  Fang Yi; Chen Zhan; Baojuan Liu; Hu Li; Jianmeng Zhou; Jiaman Tang; Wen Peng; Wei Luo; Qiaoli Chen; Kefang Lai
Journal:  Respir Res       Date:  2022-10-10

5.  Central and peripheral mechanisms of narcotic antitussives: codeine-sensitive and -resistant coughs.

Authors:  Kazuo Takahama; Tetsuya Shirasaki
Journal:  Cough       Date:  2007-07-09

6.  A retrospective study of clinical features of cough variant asthma in Chinese adults.

Authors:  Weiping Liu; Huaping Chen; Dehua Zhang; Feng Wu; Liqin Zhou
Journal:  Allergy Asthma Clin Immunol       Date:  2019-01-17       Impact factor: 3.406

Review 7.  Peripheral mechanisms II: the pharmacology of peripherally active antitussive drugs.

Authors:  D Spina; I McFadzean; F K R Bertram; C P Page
Journal:  Handb Exp Pharmacol       Date:  2009
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.